TY - JOUR
T1 - Design, Synthesis, and Evaluation of Triazole Derivatives That Induce Nrf2 Dependent Gene Products and Inhibit the Keap1-Nrf2 Protein-Protein Interaction
AU - Bertrand, Hélène C.
AU - Schaap, Marjolein
AU - Baird, Liam
AU - Georgakopoulos, Nikolaos D.
AU - Fowkes, Adrian
AU - Thiollier, Clarisse
AU - Kachi, Hiroko
AU - Dinkova-Kostova, Albena T.
AU - Wells, Geoff
PY - 2015/9/24
Y1 - 2015/9/24
N2 - The transcription factor Nrf2 regulates the expression of a large network of cytoprotective and metabolic enzymes and proteins. Compounds that directly and reversibly inhibit the interaction between Nrf2 and its main negative regulator Keap1 are potential pharmacological agents for a range of disease types including neurodegenerative conditions and cancer. We describe the development of a series of 1,4-diphenyl-1,2,3-triazole compounds that inhibit the Nrf2-Keap1 protein-protein interaction (PPI) in vitro and in live cells and up-regulate the expression of Nrf2-dependent gene products.
AB - The transcription factor Nrf2 regulates the expression of a large network of cytoprotective and metabolic enzymes and proteins. Compounds that directly and reversibly inhibit the interaction between Nrf2 and its main negative regulator Keap1 are potential pharmacological agents for a range of disease types including neurodegenerative conditions and cancer. We describe the development of a series of 1,4-diphenyl-1,2,3-triazole compounds that inhibit the Nrf2-Keap1 protein-protein interaction (PPI) in vitro and in live cells and up-regulate the expression of Nrf2-dependent gene products.
UR - http://www.scopus.com/inward/record.url?scp=84942319851&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84942319851&partnerID=8YFLogxK
U2 - 10.1021/acs.jmedchem.5b00602
DO - 10.1021/acs.jmedchem.5b00602
M3 - Article
C2 - 26348784
AN - SCOPUS:84942319851
SN - 0022-2623
VL - 58
SP - 7186
EP - 7194
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 18
ER -